December 14, 2020

Single-Patient Study Adds To Debate Over Gilead's Remdesivir For COVID-19-Reuters

A single-patient study conducted by British scientists has found that Gilead’s antiviral drug remdesivir could be highly effective against COVID-19, raising questions about previous studies that found it had no impact on death rates from the disease. Published in the journal Nature Communications, the study describes how doctors who gave the drug to a patient with both COVID-19 and a rare immune disorder saw a marked improvement in his symptoms and the disappearance of the virus. Reuters, 12/14/2020